Cargando…
Clinical Pharmacology in Sleep Medicine
The basic treatment goals of pharmacological therapies in sleep medicine are to improve waking function by either improving sleep or by increasing energy during wakefulness. Stimulants to improve waking function include amphetamine derivatives, modafinil, and caffeine. Sleep aids encompass several c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504423/ https://www.ncbi.nlm.nih.gov/pubmed/23213564 http://dx.doi.org/10.5402/2012/914168 |
_version_ | 1782250630039994368 |
---|---|
author | Proctor, Ashley Bianchi, Matt T. |
author_facet | Proctor, Ashley Bianchi, Matt T. |
author_sort | Proctor, Ashley |
collection | PubMed |
description | The basic treatment goals of pharmacological therapies in sleep medicine are to improve waking function by either improving sleep or by increasing energy during wakefulness. Stimulants to improve waking function include amphetamine derivatives, modafinil, and caffeine. Sleep aids encompass several classes, from benzodiazepine hypnotics to over-the-counter antihistamines. Other medications used in sleep medicine include those initially used in other disorders, such as epilepsy, Parkinson's disease, and psychiatric disorders. As these medications are prescribed or encountered by providers in diverse fields of medicine, it is important to recognize the distribution of adverse effects, drug interaction profiles, metabolism, and cytochrome substrate activity. In this paper, we review the pharmacological armamentarium in the field of sleep medicine to provide a framework for risk-benefit considerations in clinical practice. |
format | Online Article Text |
id | pubmed-3504423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | International Scholarly Research Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-35044232012-12-04 Clinical Pharmacology in Sleep Medicine Proctor, Ashley Bianchi, Matt T. ISRN Pharmacol Review Article The basic treatment goals of pharmacological therapies in sleep medicine are to improve waking function by either improving sleep or by increasing energy during wakefulness. Stimulants to improve waking function include amphetamine derivatives, modafinil, and caffeine. Sleep aids encompass several classes, from benzodiazepine hypnotics to over-the-counter antihistamines. Other medications used in sleep medicine include those initially used in other disorders, such as epilepsy, Parkinson's disease, and psychiatric disorders. As these medications are prescribed or encountered by providers in diverse fields of medicine, it is important to recognize the distribution of adverse effects, drug interaction profiles, metabolism, and cytochrome substrate activity. In this paper, we review the pharmacological armamentarium in the field of sleep medicine to provide a framework for risk-benefit considerations in clinical practice. International Scholarly Research Network 2012-11-14 /pmc/articles/PMC3504423/ /pubmed/23213564 http://dx.doi.org/10.5402/2012/914168 Text en Copyright © 2012 A. Proctor and M. T. Bianchi. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Proctor, Ashley Bianchi, Matt T. Clinical Pharmacology in Sleep Medicine |
title | Clinical Pharmacology in Sleep Medicine |
title_full | Clinical Pharmacology in Sleep Medicine |
title_fullStr | Clinical Pharmacology in Sleep Medicine |
title_full_unstemmed | Clinical Pharmacology in Sleep Medicine |
title_short | Clinical Pharmacology in Sleep Medicine |
title_sort | clinical pharmacology in sleep medicine |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504423/ https://www.ncbi.nlm.nih.gov/pubmed/23213564 http://dx.doi.org/10.5402/2012/914168 |
work_keys_str_mv | AT proctorashley clinicalpharmacologyinsleepmedicine AT bianchimattt clinicalpharmacologyinsleepmedicine |